MURPHY CAPITAL MANAGEMENT INC - MERRIMACK PHARMACEUTICALS IN ownership

Quarter-by-quarter ownership
MURPHY CAPITAL MANAGEMENT INC ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2016$135,000
+6.3%
16,1420.0%0.02%
+10.5%
Q4 2015$127,000
-7.3%
16,1420.0%0.02%
-17.4%
Q3 2015$137,000
-31.2%
16,1420.0%0.02%
-23.3%
Q2 2015$199,000
+4.2%
16,1420.0%0.03%
+7.1%
Q1 2015$191,000
+4.9%
16,1420.0%0.03%0.0%
Q4 2014$182,000
+29.1%
16,1420.0%0.03%
+27.3%
Q3 2014$141,000
+20.5%
16,1420.0%0.02%
+15.8%
Q2 2014$117,000
+44.4%
16,1420.0%0.02%
+35.7%
Q1 2014$81,000
-5.8%
16,1420.0%0.01%
-6.7%
Q4 2013$86,000
+41.0%
16,1420.0%0.02%
+25.0%
Q3 2013$61,000
-43.5%
16,1420.0%0.01%
-45.5%
Q2 2013$108,00016,1420.02%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 5,000,000$20,400,0004.19%
Consonance Capital Management LP 9,067,998$36,997,0004.06%
Lagoda Investment Management, L.P. 1,522,529$6,212,0002.13%
INDUS CAPITAL PARTNERS, LLC 1,050,000$4,284,0000.56%
WESTFIELD CAPITAL MANAGEMENT CO LP 9,072,877$37,017,0000.32%
GARRISON BRADFORD & ASSOCIATES INC 77,700$317,0000.29%
Cannell & Co. 1,572,978$6,418,0000.23%
Virtus ETF Advisers LLC 179,625$733,0000.22%
LeJeune Puetz Investment Counsel LLC 3,976$161,0000.12%
STONERIDGE INVESTMENT PARTNERS LLC 221,838$905,0000.12%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders